drugset / Trial / NCT01825473
Study of Erythromycin in GER-Associated Apnea of the Newborn
RandomizedParallel-groupTriple-blindTreatment
Summary
To evaluate the relationship of reflux and apnea and to determine whether the administration of erythromycin improves the incidence of GER and GER-associated apnea, bradycardic and/or desaturation events in a prospective randomized controlled trial.
Timeline
- Start
- 2012-09
- Primary completion
- 2014-03
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Erythromycin | Small molecule | 50 mg/kg | Oral |